Literature DB >> 528777

Influence of bromocriptine on plasma levels of prolactin and steroid hormones in the 20th week of pregnancy.

W D Lehmann, K Musch, A S Wolf.   

Abstract

The influence of bromocriptine, a prolactin antagonist, on maternal plasma and amniotic fluid prolactin (PRL) was investigated in two pregnancies at the 20th week with medical indication for abortion. Voluntary consensus of the patients was obtained. Blood sample determinations demonstrated that bromocriptine inhibits the secretion of PRL both in plasma and amniotic fluid. Since no changes were observed in peripheral maternal steroid concentrations of dehydroepiandrosterone, dehydroepiandrosterone-sulfate, delta 4-androstene-3, 17-dione, testosterone, estradiol, estriol, and cortisol, it is concluded that PRL does not seem to affect maternal and fetal adrenal cortex as supposed in amenorrhoic patients with hyperprolactinemia.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 528777     DOI: 10.1007/BF03350411

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  13 in total

1.  The ontogenesis of human fetal hormones. III. Prolactin.

Authors:  M J Aubert; M M Grumbach; S L Kaplan
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

2.  Endocrine studies in anencephaly.

Authors:  A Hayek; S G Driscoll; J B Warshaw
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

3.  Sources and disposition of pituitary prolactin in maternal circulation, amniotic fluid, fetus and placenta in the pregnant rhesus monkey.

Authors:  J B Josimovich; G Weiss; D L Hutchinson
Journal:  Endocrinology       Date:  1974-05       Impact factor: 4.736

4.  HCG + ACTH stimulation of in vitro dehydroepiandrosterone production in human fetal adrenals from precursor cholesterol and delta5-pregnenolone.

Authors:  W D Lehmann; C Lauritzen
Journal:  J Perinat Med       Date:  1975       Impact factor: 1.901

5.  Study on maternal, fetal, and amniotic human prolactin at term.

Authors:  V S Fang; M H Kim
Journal:  J Clin Endocrinol Metab       Date:  1975-12       Impact factor: 5.958

Review 6.  Hypothesis: placental membranes produce prolactin.

Authors:  D L Healy; H G Burger; H K Muller
Journal:  Mol Cell Endocrinol       Date:  1978-06       Impact factor: 4.102

7.  Radioligand assay for 5 -3 -hydroxysteroids. I. 3 -Hydroxy-5-androstene-17-one and its 3-sulfate.

Authors:  E Nieschlag; D L Loriaux; M B Lipsett
Journal:  Steroids       Date:  1972-05       Impact factor: 2.668

8.  Effect of prolactin on plasma DHEA (s) levels.

Authors:  A Vermeulen; E Suy; R Rubens
Journal:  J Clin Endocrinol Metab       Date:  1977-06       Impact factor: 5.958

9.  A radioimmunoassay for human prolactin.

Authors:  P Hwang; H Guyda; H Friesen
Journal:  Proc Natl Acad Sci U S A       Date:  1971-08       Impact factor: 11.205

10.  Plasma androgens in women with hyperprolactinaemic amenorrhoea.

Authors:  F Bassi; G Giusti; L Borsi; S Cattaneo; P Giannotti; G Forti; M Pazzagli; C Vigiani; M Serio
Journal:  Clin Endocrinol (Oxf)       Date:  1977-01       Impact factor: 3.478

View more
  3 in total

Review 1.  Prolactinoma through the female life cycle.

Authors:  Deirdre Cocks Eschler; Pedram Javanmard; Katherine Cox; Eliza B Geer
Journal:  Endocrine       Date:  2017-11-24       Impact factor: 3.633

2.  Maternal serum hormone changes during abortion induced with 9-deoxo-16, 16-dimethyl-9-methylene prostaglandin E2.

Authors:  K Bremme; P Eneroth; M Bygdeman
Journal:  J Endocrinol Invest       Date:  1982 Nov-Dec       Impact factor: 4.256

3.  Effect of metoclopramide on maternal and fetal hyperprolactinemia.

Authors:  G Robuschi; R Emanuele; L d'Amato; M Salvi; E Dall'Aglio; E Gardini; M Fatone; S Foscolo; A Gnudi; E Roti
Journal:  J Endocrinol Invest       Date:  1983-04       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.